Response by Aggarwal et al to Letter Regarding Article, "Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants"

被引:0
作者
Aggarwal, Rahul [1 ,2 ]
Ruff, Christian T. [3 ]
Virdone, Saverio [4 ]
Perreault, Sylvie [5 ]
Kakkar, Ajay K. [4 ,6 ]
Palazzolo, Michael G. [3 ]
Dorais, Marc [7 ]
Kayani, Gloria [4 ]
Yeh, Robert W. [1 ]
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Div Cardiol,Beth Israel Deaconess Med Ctr, Richard A & Susan F Smith Ctr Outcomes Res Cardio, Boston, MA 02115 USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Heart & Vasc Ctr, Boston, MA 02115 USA
[3] Harvard Med Sch, Brigham & Womens Hosp, Thrombolysis Myocardial Infarct Study Grp, Div Cardiovasc Med, Boston, MA USA
[4] Thrombosis Res Inst, London, England
[5] Univ Montreal, Fac Pharm, Montreal, PQ, Canada
[6] UCL, Div Surg, London, England
[7] StatSciences Inc, Notre Dame Lile Perrot, PQ, Canada
关键词
D O I
10.1161/CIRCULATIONAHA.123.068239
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:e1111 / e1112
页数:2
相关论文
共 5 条
[1]   Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants [J].
Aggarwal, Rahul ;
Ruff, Christian T. ;
Virdone, Saverio ;
Perreault, Sylvie ;
Kakkar, Ajay K. ;
Palazzolo, Michael G. ;
Dorais, Marc ;
Kayani, Gloria ;
Singer, Daniel E. ;
Secemsky, Eric ;
Piccini, Jonathan ;
Tahir, Usman A. ;
Shen, Changyu ;
Yeh, Robert W. .
CIRCULATION, 2023, 148 (12) :936-946
[2]   Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale From the COMBINE AF (A Collaboration between Multiple institutions to Better Investigate Non-vitamin K antagonist oral anticoagulant use in Atrial Fibrillation) Investigators [J].
Carnicelli, Anthony P. ;
Hong, Hwanhee ;
Giugliano, Robert P. ;
Connolly, Stuart J. ;
Eikelboom, John ;
Patel, Manesh R. ;
Wallentin, Lars ;
Morrow, David A. ;
Wojdyla, Daniel ;
Hua, Kaiyuan ;
Hohnloser, Stefan H. ;
Oldgren, Jonas ;
Ruff, Christian T. ;
Piccini, Jonathan P. ;
Lopes, Renato D. ;
Alexander, John H. ;
Granger, Christopher B. .
AMERICAN HEART JOURNAL, 2021, 233 :48-58
[3]   Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].
Connolly, Stuart J. ;
Ezekowitz, Michael D. ;
Yusuf, Salim ;
Eikelboom, John ;
Oldgren, Jonas ;
Parekh, Amit ;
Pogue, Janice ;
Reilly, Paul A. ;
Themeles, Ellison ;
Varrone, Jeanne ;
Wang, Susan ;
Alings, Marco ;
Xavier, Denis ;
Zhu, Jun ;
Diaz, Rafael ;
Lewis, Basil S. ;
Darius, Harald ;
Diener, Hans-Christoph ;
Joyner, Campbell D. ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151
[4]   International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD) [J].
Kakkar, Ajay K. ;
Mueller, Iris ;
Bassand, Jean-Pierre ;
Fitzmaurice, David A. ;
Goldhaber, Samuel Z. ;
Goto, Shinya ;
Haas, Sylvia ;
Hacke, Werner ;
Lip, Gregory Y. H. ;
Mantovani, Lorenzo G. ;
Verheugt, Freek W. A. ;
Jamal, Waheed ;
Misselwitz, Frank ;
Rushton-Smith, Sophie ;
Turpie, Alexander G. G. .
AMERICAN HEART JOURNAL, 2012, 163 (01) :13-U31
[5]   Predicting major bleeding among hospitalized patients using oral anticoagulants for atrial fibrillation after discharge [J].
Qazi, Jakub Z. ;
Schnitzer, Mireille E. ;
Cote, Robert ;
Martel, Marie-Josee ;
Dorais, Marc ;
Perreault, Sylvie .
PLOS ONE, 2021, 16 (03)